Ortin Laboratories Limited reported earnings results for the fourth quarter and full year ended March 31, 2022. For the fourth quarter, the company reported sales was INR 22.94 million compared to INR 17.57 million a year ago. Revenue was INR 24.52 million compared to INR 18.07 million a year ago. Net loss was INR 4.53 million compared to net income of INR 8.05 million a year ago. Basic loss per share from continuing operations was INR 0.56 compared to basic earnings per share from continuing operations of INR 0.99 a year ago.
For the full year, sales was INR 82.31 million compared to INR 81.67 million a year ago. Revenue was INR 84.25 million compared to INR 82.18 million a year ago. Net loss was INR 3.99 million compared to net income of INR 9.46 million a year ago. Basic loss per share from continuing operations was INR 0.49 compared to basic earnings per share from continuing operations of INR 1.16 a year ago.